Implantation of an Isoproterenol Mini-Pump to Induce Heart Failure in Mice.
Isoproterenol (ISO), is a non-selective beta-adrenergic agonist, that is used widely to induce cardiac injury in mice. While the acute model mimics stress-induced cardiomyopathy, the chronic model, administered through an osmotic pump, mimics advanced heart failure in humans. The purpose of the described protocol is to create the chronic ISO-induced heart failure model in mice using an implanted mini-pump. This protocol has been used to induce heart failure in 100+ strains of inbred mice. Techniques on surgical pump implantation are described in detail and may be relevant to anyone interested in creating a heart failure model in mice. In addition, the weekly cardiac remodeling changes based on echocardiographic parameters for each strain and expected time to model development are presented. In summary, the method is simple and reproducible. Continuous ISO administered via the implanted mini-pump over 3 to 4 weeks is sufficient to induce cardiac remodeling. Finally, the success for ISO model creation may be assessed in vivo by serial echocardiography demonstrating hypertrophy, ventricular dilation, and dysfunction.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
DOI
EISSN
Publication Date
Issue
Location
Related Subject Headings
- Prosthesis Implantation
- Osmosis
- Mice
- Male
- Isoproterenol
- Heart Failure
- Echocardiography
- Disease Models, Animal
- Animals
- Anesthesia
Citation
Published In
DOI
EISSN
Publication Date
Issue
Location
Related Subject Headings
- Prosthesis Implantation
- Osmosis
- Mice
- Male
- Isoproterenol
- Heart Failure
- Echocardiography
- Disease Models, Animal
- Animals
- Anesthesia